Navigation Links
Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes
Date:12/16/2011

be accessed following the teleconference.  The teleconference call will also be available for replay starting Friday, December 16, 2011 at 10:30 A.M. Eastern Time through Friday, December 23, 2011 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 230017.

About Kensey Nash Corporation.  Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.  For more information, visit www.kenseynash.com.

Cautionary Note for Forward-Looking Statements.  This press release contains forward-looking statements, including the statements regarding the Company's view as to how long Angio-Seal royalty payments will be due and the Company's other expectations as to future royalty payments to be received from St. Jude Medical, as well as the potential impact of St. Jude's actions and the related proceedings on the Company's operating results.  The forward-looking statements are covered by the "Safe Harbor for Forward-Looking Statements" provided by the Private Securities Litigation Reform Act of 1995.  The Company has tried to identify the forward-looking-statements by using words such as "plan," "expect," "will," "would," "should," "believe," "guidance" and similar expressions, but these words are not the exclusive means for identifying such statements.  The Company cautions that a number of risks, uncertainties and other important factors could cause the Company's actual results to differ ma
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kensey Nash Announces IDE Submission for Cartilage Repair Device
2. Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
3. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
4. Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results
5. Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product
6. Kensey Nash Announces $30 Million Share Buyback
7. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
8. Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum
9. Kensey Nash Corporation Announces the Addition of Donald Morel, Jr., Ph.D. to Its Board of Directors
10. Kensey Nash to Present at the Ninth Annual JMP Securities Research Conference
11. KENSEY NASH Receives FDA 510(k) Clearance for ECM Product, Meso BioMatrix Surgical Mesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... TEL AVIV, Israel , March 30, 2015   ... , announced the closing of $12.5 million in new financing ... the Viola Group. The funding will further GlassesUSA,s aggressive business ... the growing global market of online eyewear, both B2C and ... Daniel Rothman , COO Eldad Rothman , and ...
(Date:3/30/2015)... 2015  Zimmer Holdings, Inc. (NYSE and SIX: ... ("EC") has conditionally cleared Zimmer,s proposed acquisition of ... upon Zimmer entering into agreements with a suitable ... package previously submitted to the EC.  Zimmer expects ... term.  As previously announced, the proposed transaction also ...
(Date:3/30/2015)... , March 30, 2015  The future ... to involve more data analytics; new, more precise ... imaging and motion management techniques.  Some 150 researchers ... ideas last week at a symposium on research ... ).     "Researchers are developing, testing, ...
Breaking Medicine Technology:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 2Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 4Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 5Radiation Oncology Researchers Glimpse the Future of Cancer Care 2Radiation Oncology Researchers Glimpse the Future of Cancer Care 3Radiation Oncology Researchers Glimpse the Future of Cancer Care 4Radiation Oncology Researchers Glimpse the Future of Cancer Care 5Radiation Oncology Researchers Glimpse the Future of Cancer Care 6
(Date:3/30/2015)... Jose, California (PRWEB) March 30, 2015 ... Defined as radioactive isotopes, radiopharmaceuticals are used as ... The global market for radiopharmaceuticals is driven by ... procedures in the field of cardiology, neurology, pulmonology, ... supported by the well-established use of radioisotopes in ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 South Coast Surety ... a Surety Bond Representative. Richard has been known to the ... decade. , Richard attended the University of Georgia, majoring in ... decades in the sales and sales management of business equipment ... , Most recently, Richard was a senior officer with ...
(Date:3/30/2015)... DC (PRWEB) March 30, 2015 Daily ... toll on the face, causing wrinkles, folds and other ... invasive techniques empower men and women to hit the ... time. Today, there’s a nip, tuck or hack to ... of Facial Plastic and Reconstructive Surgery (AAFPRS) explores ...
(Date:3/30/2015)... States (PRWEB) March 30, 2015 Poo puts ... anything that could be better than Paleo, or better than ... out Poo - just released on the app store! ... step counting, there is a whole other half to that ... , With Poo, users do the dirty work, and then ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Mid-America ... mobile library of medications used in behavioral health ... iPhone, iPad and Android—is a convenient, electronic version ... since 1999. The useful resource provides up-to-date information ... dosage and frequency, side effects, emergency conditions, cautions, ...
Breaking Medicine News(10 mins):Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 2Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 3Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 4Health News:Richard Ford Joins South Coast Surety Contract Surety Team 2Health News:New AAFPRS Infographic Addresses Concerns and Provides Aging Face Solutions 2Health News:Popular Publication on Behavioral Health Medications Now An App 2
... (BPA) -- a substance that may have harmful health ... register receipts, scientists are reporting. The recycling of those ... of paper napkins, toilet paper, food packaging and other ... for cashiers and other people who routinely handle thermal ...
... a major earthquake experienced high levels of post-traumatic stress disorder ... affected, according to a study published in the November issue ... led by the West China School of Nursing and West ... 12 to 20 years of age three months after the ...
... a biochemist at the University of the Basque Country (UPV/EHU), ... term, the early diagnosis of cancer of the large intestine ... known as peptidases and their activity (working rate): she has ... at different stages of the disease. If these fluctuations could ...
... , WEDNESDAY, Oct. 26 (HealthDay News) -- People ... attempt to boost their social status, a new study suggests. ... portions with higher social standing. For example, study participants believed ... social status than those who chose a medium or small ...
... -- A new potential leukemia therapy targets only cancer ... chemotherapy treatments affect cancer cells and healthy cells, causing ... anxiety and depression. This research is being presented ... Annual Meeting and Exposition in Washington, D.C., Oct. 23 ...
... It is known that a high proportion of dense breast ... high risk of breast cancer. But the role of non-dense ... published in BioMed Central,s open access journal Breast Cancer ... fibroglandular tissue, and fat, and shows that large areas of ...
Cached Medicine News:Health News:Teenage girls and senior students suffered highest levels of PTSD after major earthquake 2Health News:Teenage girls and senior students suffered highest levels of PTSD after major earthquake 3Health News:Steps being taken towards achieving an early diagnosis of cancer of the large intestine 2Health News:Steps being taken towards achieving an early diagnosis of cancer of the large intestine 3Health News:Larger Food Portions May Be Seen as Status Symbols 2
The Streck-MD-Pack is specially designed for use on Coulter® MD Series instruments. Each pack contains diluent and lysing agent. The shelf life is one year from date of manufacture....
A lytic reagent manufactured for the simultaneous quantitative determinations of hemoglobin and white blood cells. Streck-Lysing Agent III is for use on the Abbott CELL-DYN® 1400 and 1600. The sh...
Streck-Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3000. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Medicine Products: